Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for sharing.
It's so new, I hadn't even seen the document yet, so I appreciate your post.
You're our new 'go to guy'!
It's amazing to me, how Sessions can be so archaic in his views and can only hope that his plate is so full with other items, including the continuing positive supporting marijuana data from many sectors, that he is undergoing a change of thinking?
Can you imagine the bizzare scenario where factors evolve where Sessions is canned, etc., and eventually loyally compliant soon to be ex new jersey governor becomes new AG with his marijuana views?
Yup, buy the dip!
Here is more 'meat!'
"Sessions’ marijuana task force report gives him no ammo to go after legal states"
http://www.thecannabist.co/2017/08/04/sessions-marijuana-task-force-report/85436/
The biggest concern from the U.S. And Canadian governments is controlling the cash flow and profits made in which Country. I believe since the position that Aphria is holding with Liberty Health Service is a non controlling position at 38% it won't be an issue moving forward. There will be tight controls to measure the profits and hiding of profits under the 3% royalty of sales.
If it is still a an illegal substance at the Federal Level this royalty will never be able to be paid out to Aphria and the share percentage could be increased to offset that agreement. There are no laws that govern foreign stock ownership by another company as long as it is documented which in this case is fully disclosed in Audited Financial Statements. Aphria is able to purchase the stock just like you and I through various brokers. I am a Canadian and I too hold both Aph on the TSX and APHQF on the OTC.
In two months time Aphria will be cultivating 10,000 kilos of MJ in a quarter and on the path to $100 million quarterly revenue. This company is far from being in trouble.
Thanks for putting so much helpful informative 'meat' in reaction to my post.
IMO, If we can keep State's Rights growing and keep the giant pharmas, etc. at bay,I am of the feeling that massive investment growth awaits us nationwide and internationally.
Yes the real reason Governments around the world are legalizing MJ is because they are starved for cash.
The same happened during the Great Depression and the legalization of alcohol.
Expect legalization to get stronger as technologies empower the public and government tax sources are dried out:
Read UBER, AIRBNB...
Taxis license revenues gone
Hotel and commercial taxes gone
More and more they are being left to dry
Marijuana will be rescheduled or in the least be left alone...
Trump said it.
Session has his hands tied and has a bigger war to fight with Opioids.
"U.S. Cannabis Industry is Booming in 2017
U.S. cannabis stocks have been kind of weak on the chart in 2017. But if you look at company fundamentals, you will see the cannabis industry firing on all cylinders.
That was on display this week with more good news from one of the fastest growing medical cannabis markets in the U.S.
Four new medical cannabis dispensaries are set to open in Long Island as New York moves to double its medical program.
The New York Health Department recently awarded five licenses to new medical marijuana companies. Once these new companies are operational New York will be home to 10 manufacturing sites and 40 dispensaries across the state.
For the time being these permits are being rewarded to privately owned companies.
For example, Fiorella Pharmaceuticals is one winner. The company will operate a manufacturing facility in Schenectady County and dispensaries in Nassau, Monroe, New York and Saratoga counties.
This wave of new permits comes in response to New York's booming medical cannabis market.
After coming online in 2016, the most recent data shows there are 25,736 registered patients in New York's medical marijuana program, an increase of more than 10,000 patients since March when chronic pain was added to the list of treatable conditions.
When the medical program launched last year, only 10 conditions were included for treatment. Today that list has has already expanded by 50% to 15 conditions.
Moving forward, as more conditions are added to the list, it will enable more patients to access medical cannabis.
But even more important than additional indications for medical cannabis - the success of New York's medical market sets the stage for the state to eventually legalize recreational cannabis.
Recreational cannabis sales have the potential to generate huge taxes for politicians who are starved for cash.
According to reports, New Yorkers spend more than $3 billion every year on illegal cannabis. Regulating the industry could provide hundreds of millions in new taxes.
A study conducted by the NYC comptroller in 2013 projected potential tax revenue for legal cannabis in New York City alone could top $400 million.
A group of New York lawmakers recently reintroduced the Marijuana Regulation and Taxation Act that would legalize cannabis. Although the bill has little chance of clearing a Republican-led Senate it a clear indication of where the legislators are headed.
New York legalizing recreational cannabis would be a big win for the U.S. cannabis industry and create some great investment opportunities.
Because recent events show that demand for recreational cannabis is basically off the charts.
Look no further than Nevada for a great example.
Recreational Cannabis Sales in Nevada are Crushing Expectations
Recreational cannabis began being sold in Nevada on July 1. So far, demand is off the charts and lawmakers had to introduce emergency regulations to help keep the market supplied.
As you can see, the U.S. cannabis industry is having another great year. There's been a steady stream of good news our of the industry lately. More states have legalized. New cannabis programs are taking flight. Sales are hitting new highs. The recent string of good news gave U.S. cannabis stocks a shot in the arm. The U.S. cannabis index rallied almost 20% in the last month.
However, the U.S. cannabis index is still down about 25% on the year. In fact, U.S. cannabis stocks have been stuck in a downtrend since topping off in November of 2016. Take a look at the downtrend below. That weakness is being driven by uncertainty over U.S. drug policy. New U.S .Attorney General Jeff Sessions is an outspoken opponent of cannabis and has expressed an interesting in cracking down on the industry. That has caused a lot of uncertainty in the cannabis industry and squeezed a lot of capital out of U.S. cannabis stocks.
Looking Forward There Are Two Trigger Points For U.S. Cannabis Stocks
The U.S. cannabis index is trying to break this downtrend that has been in play for the last nine months.If this downtrend is broken, I would expect U.S. cannabis stocks to see a very big rally off these recent lows.
The second and bigger trigger for U.S. cannabis stocks is legislative. I am expecting more states to legalize - but I am talking about something much bigger than that. For example, federal legislation to legalize medical cannabis. Or even federal legislation to legalize recreational cannabis. Either of those events would be huge for the U.S. cannabis industry and U.S. cannabis stocks would rip higher on the news.
The Big Picture on U.S. Cannabis Stocks
The U.S. cannabis industry is booming in 2017. Recent news out of New York and Nevada showcase how fast the industry is growing. U.S. cannabis stocks are down in the short run over legislative concerns. For the time being be patient with U.S. cannabis stocks. But if we see any major federal legislative wins - I would expect it to ignite a sustained rally and that would be the time to load up and be aggressive."
I'm Canadian & OTC is available to me through Royal Bank of Canada and all other 5 major banks. I own both APH and APHQF, respectively TSX and OTC symbols.
If (and that's s HUGE IF) CDS drops out from clearing funds for APH on TSX I'm buying more APHQF. Simple as that.
The article is an opinion based here-say speculation Globe & Mail article (the newspaper that published it). The CDS never "formally discussed" this issue. That quote is actually in the initial article. Just read it slowly.
Also in the Globe article the author l mentions that CDS may actually NOT EVEN HAVE THE AUTHORITY to pull out as a clearing house.
U.S. legalization is way off at the federal level, medical MJ rescheduling is a much more achievable goal over the short term
Like i suggested last night, APHRIA sure appears to be on SALE and those with a risk disposition, will see this as bargain prices for Aphria.
Also of note, there's a heavily supported, bi partisan bill in the US Congress to legalize marijuana, which sure seems to make sense given the overwhelming number of states that have already acted.
Issues of medical value grow stronger everyday.
And the biggest factor of all, the MILLIONS in tax revenue being generated by tax starved states.
And Ohio ..
55 m ... I agree I love APHRIA but you don't risk a billion dollar company ..... technical us Feds could seize this company ....
They won't .......
But I had to sell couldn't risk 26 k on what if ... :(
The lure of U.S. proved too strong. I believe Aphria will come through this fine. Vic doesn't strike me as a CEO to have made a blatant error.
Might have to sell off their U.S. investment in Florida.
Hoping we see $3 again. Would be a blessing to load the boat once more.
Holding till 2020 anyways, so who cares about the month-to-month or even the quarter-to-quarter fluctuations.
APHRIA IS KING
gotcha, thanks, i'll dig more when i get time.
not worried though...CAN is pot happy. we are fine.
The noise is one "IF this happens" article that was written this week. Read threads below. You'll see it.
The CDA hasn't even sat down nor have they the authority to pull the plug on what is about $5BILLION worth of stocks traded on TSX.
This shall prove nothing more than just an opinionated article based on heresay.
Notice how the article mentioned "sources say" but cites no sources?
Article also mentioned that CDA may not even have any authority to pull plug from TSX or CSE listings.
They are just a clearing house. Ok going back bed.
can you pm me what the "noise" was?
Exactly, APH is a giant. They also hold stake in medical MJ in USA. As I said, noise, this shall pass
what article did i miss? I'm holding long too. these guys have massive margins and are a front runner in the industry. if anything I'll load more and avg down from 5.3
There breaking security laws it's a big deal ... CEO f up should stayed in Canada .
Amazing how one "IF" article can induce a sell off.
Im sitting tight. Nothing has changed here.
Just noise. "It is still uncertain whether TMX will decide to do that; it’s not even clear whether CDS, which is highly regulated, has the authority to do so."
?????? Canadian Companies With Exposure To The U.S Could Be Facing Some Pressure ?????? https://technical420.com/cannabis-article/which-marijuana-stocks-will-be-impacted-tsx-shakeup
Yes my bad, I mistook the date for another company's earnings.
I noted the following quotes on the article: "It is still uncertain whether TMX will decide to do that; it’s not even clear whether CDS, which is highly regulated, has the authority to do so."
“We are monitoring ongoing developments in the #marijuana industry,” a spokesman for CDS said in an e-mailed statement. “This monitoring process includes considering the potential effects ... on CDS and its participants, as well as the public interest.”
https://www.theglobeandmail.com/report-on-business/streetwise/stock-trading-policy-change-looms-over-cannabis-industry/article35870664/
What are you talking about, earnings were out on July 12. I think this is all about TSX rules regarding foreign investments.
Earnings Announcement tomorrow. Hence the sell off due to uncertainty.
TSX rules about US Investments could be hurting this stock
https://beta.theglobeandmail.com/globe-investor/investment-ideas/us-pot-laws-are-a-headache-for-the-tsx/article35826145/?ref=http://www.theglobeandmail.com&
Saying they might halt trading with companies , that have investments in America ... that's why I sold ...
I hear what you're saying and if it helps, this is a high quality stock and just give it time as , imo, it's going much higher over time.
Unfortunately you bought near the top and after a very strong move up.
It doesn't take a lot of shares to move the stock, so today's sellers could easily be tomorrow's buyers.
If i were in your position, I would strongly consider some dollar cost averaging purchasing, assuming you still believe in the stock's potential.
GLTY.
On sale today??? I bought it for 5.84 USD back in April and it's been on sale ever since. I have been trying to get the "on sale" price to go up to the break even price.
Things are about o get very interesting!!!
https://www.vibe.com/2017/08/cory-booker-introduces-bill-to-legalize-marijuana/
APHRIA ON SALE TODAY!
Great day to take advantage of this momentary weakness.
A definite cannabis stock for one's cannabis portfolio.
The future potential is really quite staggering revenue/earnings wise.
Fun fun fun! 2018 double digits dollars no doubt !
Agreed, posts here do nothing to pps, lol just fun! $APHRIA 2018
i don't sweat the fluctuations... this company is primed to blow. their margins are insane, they have huge revenues and are growing by leaps and bounds in a soon to be fully recreational country. BUY AND HOLD
Great news on the royalties deal with Liberty! and man, the margins these guys have are insane. I can't get enough shares here...
Check out whos in charge....
https://libertyhealthsciences.com/
Followers
|
330
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
16650
|
Created
|
10/02/16
|
Type
|
Free
|
Moderators |
https://aphria.ca/
PO Box 20009 269 Erie St South
Leamington, ON N8H 3C4
214 King Street West, Suite 412 Toronto,
ON M5H 3S6
Aphria is a Health Canada Licensed Producer of medical cannabis products. Our quality medical cannabis is 100% greenhouse grown.
100% Greenhouse Grown- Our plants thrive from the many benefits of natural sunlight in our state-of-the-art greenhouse.
Safe and Consistent Products- Aphria goes beyond industry standards to ensure patients receive clean, safe, and pure medical cannabis products.
Superior Patient Care- Our compassionate and knowledgeable Patient Care Team is here to assist you every step of the way.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |